Want to track FULC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fulcrum Therapeutics Inc. (FULC) Statistics
Valuation metrics
Market Cap 287.64M
Enterprise value 244.45M
Trailing P/E (ttm) -3.12
Forward P/E -
PEG ratio -8.22
Price/Sales (ttm) -
Price/Book (mrq) 0.93
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.8M
Average volume (90 days) 1.05M
Price summary
52-Week low 2.83
52-Week high 15.74
Beta -
50-Day moving average 3.79
200-Day moving average 6.4
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.26%
Return on equity -0.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 31.35%
Book value per share (mrq) 4.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
